FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:SAE1-ARHGAP35

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: SAE1-ARHGAP35
FusionPDB ID: 79004
FusionGDB2.0 ID: 79004
HgeneTgene
Gene symbol

SAE1

ARHGAP35

Gene ID

10055

2909

Gene nameSUMO1 activating enzyme subunit 1Rho GTPase activating protein 35
SynonymsAOS1|HSPC140|SUA1|UBLE1AGRF-1|GRLF1|P190-A|P190A|p190ARhoGAP|p190RhoGAP
Cytomap

19q13.32

19q13.32

Type of geneprotein-codingprotein-coding
DescriptionSUMO-activating enzyme subunit 1SUMO-1 activating enzyme E1 N subunitSUMO-1 activating enzyme subunit 1activator of SUMO1sentrin/SUMO-activating protein AOS1ubiquitin-like 1-activating enzyme E1Aubiquitin-like protein SUMO-1 activating enzymerho GTPase-activating protein 35glucocorticoid receptor DNA-binding factor 1glucocorticoid receptor repression factor 1rho GAP p190A
Modification date2020031320200313
UniProtAcc.

Q9NRY4

Main function of 5'-partner protein: FUNCTION: Rho GTPase-activating protein (GAP) (PubMed:19673492, PubMed:28894085). Binds several acidic phospholipids which inhibits the Rho GAP activity to promote the Rac GAP activity (PubMed:19673492). This binding is inhibited by phosphorylation by PRKCA (PubMed:19673492). Involved in cell differentiation as well as cell adhesion and migration, plays an important role in retinal tissue morphogenesis, neural tube fusion, midline fusion of the cerebral hemispheres and mammary gland branching morphogenesis (By similarity). Transduces signals from p21-ras to the nucleus, acting via the ras GTPase-activating protein (GAP) (By similarity). Transduces SRC-dependent signals from cell-surface adhesion molecules, such as laminin, to promote neurite outgrowth. Regulates axon outgrowth, guidance and fasciculation (By similarity). Modulates Rho GTPase-dependent F-actin polymerization, organization and assembly, is involved in polarized cell migration and in the positive regulation of ciliogenesis and cilia elongation (By similarity). During mammary gland development, is required in both the epithelial and stromal compartments for ductal outgrowth (By similarity). Represses transcription of the glucocorticoid receptor by binding to the cis-acting regulatory sequence 5'-GAGAAAAGAAACTGGAGAAACTC-3'; this function is however unclear and would need additional experimental evidences (PubMed:1894621). {ECO:0000250|UniProtKB:P81128, ECO:0000250|UniProtKB:Q91YM2, ECO:0000269|PubMed:1894621, ECO:0000269|PubMed:19673492, ECO:0000269|PubMed:28894085}.
Ensembl transtripts involved in fusion geneENST idsENST00000270225, ENST00000392776, 
ENST00000413379, ENST00000540850, 
ENST00000598840, 
ENST00000598548, 
ENST00000404338, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score17 X 10 X 12=204014 X 8 X 8=896
# samples 1914
** MAII scorelog2(19/2040*10)=-3.42449782852791
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(14/896*10)=-2.67807190511264
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: SAE1 [Title/Abstract] AND ARHGAP35 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: SAE1 [Title/Abstract] AND ARHGAP35 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ARHGAP35(47425613)-SAE1(47673075), # samples:2
SAE1(47673180)-ARHGAP35(47491246), # samples:2
Anticipated loss of major functional domain due to fusion event.ARHGAP35-SAE1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ARHGAP35-SAE1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SAE1-ARHGAP35 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SAE1-ARHGAP35 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
SAE1-ARHGAP35 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
SAE1-ARHGAP35 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ARHGAP35-SAE1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
ARHGAP35-SAE1 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF.
ARHGAP35-SAE1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneSAE1

GO:0016925

protein sumoylation

15660128|20164921

HgeneSAE1

GO:0033235

positive regulation of protein sumoylation

10187858



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:47425613/chr19:47673075)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across SAE1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ARHGAP35 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000413379SAE1chr1947673180+ENST00000404338ARHGAP35chr1947491246+5898835181508496
ENST00000540850SAE1chr1947673180+ENST00000404338ARHGAP35chr1947491246+55795169092084391
ENST00000598840SAE1chr1947673180+ENST00000404338ARHGAP35chr1947491246+564658391256415
ENST00000270225SAE1chr1947673180+ENST00000404338ARHGAP35chr1947491246+5864801291474481
ENST00000392776SAE1chr1947673180+ENST00000404338ARHGAP35chr1947491246+5832769361442468

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000413379ENST00000404338SAE1chr1947673180+ARHGAP35chr1947491246+0.0030228340.9969772
ENST00000540850ENST00000404338SAE1chr1947673180+ARHGAP35chr1947491246+0.0041035620.99589646
ENST00000598840ENST00000404338SAE1chr1947673180+ARHGAP35chr1947491246+0.0033245870.9966754
ENST00000270225ENST00000404338SAE1chr1947673180+ARHGAP35chr1947491246+0.0029643350.9970356
ENST00000392776ENST00000404338SAE1chr1947673180+ARHGAP35chr1947491246+0.0030357650.9969643

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for SAE1-ARHGAP35

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
SAE1chr1947673180ARHGAP35chr1947491246583191ALKRTTSDYFLLQGLSTEGIYRVSGN
SAE1chr1947673180ARHGAP35chr1947491246769244ALKRTTSDYFLLQGLSTEGIYRVSGN
SAE1chr1947673180ARHGAP35chr1947491246801257ALKRTTSDYFLLQGLSTEGIYRVSGN
SAE1chr1947673180ARHGAP35chr1947491246835272ALKRTTSDYFLLQGLSTEGIYRVSGN

Top

Potential FusionNeoAntigen Information of SAE1-ARHGAP35 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SAE1-ARHGAP35_47673180_47491246.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SAE1-ARHGAP35chr1947673180chr1947491246801HLA-B40:05SDYFLLQGL0.76180.5029615
SAE1-ARHGAP35chr1947673180chr1947491246801HLA-B47:01SDYFLLQGL0.2950.9105615

Top

Potential FusionNeoAntigen Information of SAE1-ARHGAP35 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
SAE1-ARHGAP35_47673180_47491246.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0101TTSDYFLLQGLSTEG419
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0101TSDYFLLQGLSTEGI520
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0105TTSDYFLLQGLSTEG419
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0105TSDYFLLQGLSTEGI520
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0107TTSDYFLLQGLSTEG419
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0107TSDYFLLQGLSTEGI520
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0111TTSDYFLLQGLSTEG419
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0111TSDYFLLQGLSTEGI520
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0115TTSDYFLLQGLSTEG419
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0119TTSDYFLLQGLSTEG419
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0119TSDYFLLQGLSTEGI520
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0125TTSDYFLLQGLSTEG419
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0125TSDYFLLQGLSTEGI520
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0127TTSDYFLLQGLSTEG419
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0127TSDYFLLQGLSTEGI520
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0129TTSDYFLLQGLSTEG419
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0129TSDYFLLQGLSTEGI520
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0131TTSDYFLLQGLSTEG419
SAE1-ARHGAP35chr1947673180chr1947491246801DRB1-0131TSDYFLLQGLSTEGI520

Top

Fusion breakpoint peptide structures of SAE1-ARHGAP35

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
8494SDYFLLQGLSTEGISAE1ARHGAP35chr1947673180chr1947491246801

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of SAE1-ARHGAP35

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN8494SDYFLLQGLSTEGI-7.15543-7.26883
HLA-B14:023BVN8494SDYFLLQGLSTEGI-4.77435-5.80965
HLA-B52:013W398494SDYFLLQGLSTEGI-6.80875-6.92215
HLA-B52:013W398494SDYFLLQGLSTEGI-4.20386-5.23916
HLA-A11:014UQ28494SDYFLLQGLSTEGI-7.5194-8.5547
HLA-A11:014UQ28494SDYFLLQGLSTEGI-6.9601-7.0735
HLA-A24:025HGA8494SDYFLLQGLSTEGI-7.52403-7.63743
HLA-A24:025HGA8494SDYFLLQGLSTEGI-5.82433-6.85963
HLA-B27:056PYJ8494SDYFLLQGLSTEGI-3.28285-4.31815
HLA-B44:053DX88494SDYFLLQGLSTEGI-5.91172-6.94702
HLA-B44:053DX88494SDYFLLQGLSTEGI-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of SAE1-ARHGAP35

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
SAE1-ARHGAP35chr1947673180chr1947491246615SDYFLLQGLCCGACTACTTTCTCCTTCAAGGACTGA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
SAE1-ARHGAP35chr1947673180chr1947491246419TTSDYFLLQGLSTEGCGACCTCCGACTACTTTCTCCTTCAAGGACTGAGCACGGAAGGCA
SAE1-ARHGAP35chr1947673180chr1947491246520TSDYFLLQGLSTEGICCTCCGACTACTTTCTCCTTCAAGGACTGAGCACGGAAGGCATCT

Top

Information of the samples that have these potential fusion neoantigens of SAE1-ARHGAP35

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADSAE1-ARHGAP35chr1947673180ENST00000270225chr1947491246ENST00000404338TCGA-BR-8289-01A

Top

Potential target of CAR-T therapy development for SAE1-ARHGAP35

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to SAE1-ARHGAP35

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to SAE1-ARHGAP35

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource